Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Columbia Laboratories, Inc. (NasdaqCM: CBRX) today reported financial results for the three-month period ended March 31, 2013. Highlights of the first quarter include:
•Total net revenues increased 65% to $6.3 million in the first quarter of 2013, compared to $3.8 million in the first quarter of 2012, driven primarily by a $2.6 million increase in net product revenues from Merck Serono S.A. (“Merck Serono”) and, to a lesser extent, higher royalty revenues from Actavis, Inc. (“Actavis”).
Help employers find you! Check out all the jobs and post your resume.
